1. Introduction

Animal cloning is a biotechnology process through which an animal is reproduced using genetic material from an existing animal. One of the most recognised techniques is Somatic Cell Nuclear Transfer (SCNT), in which the nucleus of a somatic cell is transferred into an egg cell whose nucleus has been removed. The reconstructed embryo is then stimulated to develop and may be implanted into a surrogate animal.

Animal cloning research has potential applications in Morocco, particularly in:

Improving livestock breeds such as cattle, sheep and goats.

Preserving endangered and indigenous animal breeds.

Increasing agricultural productivity.

Reproducing animals with desirable genetic characteristics.

Supporting veterinary medicine and biomedical research.

Preserving valuable genetic resources.

However, animal cloning raises significant legal and ethical concerns, including animal suffering, embryo loss, genetic diversity, reproductive health, environmental protection and the commercial exploitation of biotechnology.

Important legal distinction: Morocco's legal framework contains legislation relevant to animal health, veterinary practice, agricultural research, animal protection, biotechnology and environmental safety. It is important not to assume that these laws establish a comprehensive, express prohibition or licensing system specifically for animal cloning. The legality of a particular cloning experiment must be assessed under the applicable legislation and administrative requirements.

2. Legal and Regulatory Framework in Morocco

Morocco regulates animal-related biotechnology through several overlapping legal instruments. These instruments do not all address cloning directly, but they may apply to the animals, biological materials, research facilities and commercial products involved.

A. Law No. 29-05 on the Protection of Wild Flora and Fauna

Law No. 29-05 of 2011 concerns the protection of wild plant and animal species and the regulation of their trade.

Its relevance to animal cloning includes:

Protection of endangered species: Cloning projects involving protected wild animals must respect applicable conservation requirements.

Captive breeding: The keeping and breeding of protected species are subject to regulatory controls.

Import and export: Movement of protected animals and relevant specimens may require permits and documentation.

Reproduction and multiplication: The legislation addresses the reproduction and multiplication of protected wildlife.

Conservation obligations: Cloning must not be used to circumvent wildlife-protection requirements.

For example, a research institution seeking to clone an endangered Moroccan wild animal cannot assume that the cloning technique itself removes the need for wildlife-related permissions.

Source: Morocco Law No. 29-05.

B. Law No. 28-07 on Food Safety

Law No. 28-07, promulgated in 2010, regulates the health safety of food products.

It is relevant where cloned animals or their biological products are intended for food production.

Important regulatory considerations include:

Animal health and disease prevention.

Food safety inspections.

Veterinary and sanitary certification.

Traceability of animal-derived products.

Import and export controls.

Protection of consumers against unsafe food.

The National Office for Food Safety (ONSSA) plays an important role in implementing food-safety and animal-health requirements.

However, compliance with ordinary food-safety legislation should not automatically be interpreted as approval of cloned animals or their products.

Source: ONSSA – Food Safety Legislation.

C. Law No. 11-03 on Environmental Protection

Law No. 11-03 provides a general framework for environmental protection and sustainable development.

Animal cloning research may raise environmental questions where it involves:

Release of cloned animals into natural ecosystems.

Introduction of cloned animals into protected habitats.

Genetic effects on indigenous animal populations.

Possible loss of genetic diversity.

Unintended ecological consequences.

The environmental consequences of a research project should therefore be assessed under applicable environmental legislation and administrative requirements.

A cloned animal is not automatically an environmental hazard, but its introduction into an ecosystem may require careful scientific and regulatory assessment.

The Moroccan Ministry of Health's legislation directory identifies Law No. 11-03 among the country's environmental protection instruments.

sante.gov.ma+1

D. Law No. 47-14 of 2019: Human Reproductive Cloning

Law No. 47-14 concerning medically assisted human reproduction expressly prohibits human reproductive cloning under Article 4.

Article 4 establishes that medically assisted reproduction must not compromise the integrity of the human species and prohibits reproductive cloning and eugenics.

Article 7 also prohibits research on human embryos and foetuses.

Important distinction: These provisions concern human reproduction and human embryos. They should not be incorrectly presented as a direct statutory prohibition on animal cloning.

Nevertheless, they demonstrate Morocco's legislative approach to certain ethical issues associated with reproductive biotechnology.

Source: Law No. 47-14 – Full Legislative Text.

E. Moroccan Biosafety Framework

Morocco's biosafety framework is particularly relevant when animal cloning is combined with genetic modification or other modern biotechnology.

The Convention on Biological Diversity's Biosafety Clearing-House records Morocco's historical regulatory position, including the 1999 agricultural circular and the establishment of a National Biosafety Committee through Circular No. 5/2005.

The historical national reporting also identified the absence of a comprehensive legislative framework for living modified organisms.

However, animal cloning and genetic modification are not legally identical:

Cloning reproduces an existing genetic combination through a reproductive technique.

Genetic modification involves deliberately altering genetic material.

A cloned animal is not necessarily a genetically modified organism.

Consequently, biosafety requirements applicable to genetically modified organisms cannot automatically be applied to every animal-cloning experiment.

Sources:

Morocco+2

3. Restrictions on Animal Cloning Research

Animal cloning research in Morocco raises several important regulatory issues.

A. Restrictions on Reproductive Cloning

Reproductive cloning aims to produce a living animal genetically similar to the donor animal.

Potential restrictions may arise from:

Animal-health requirements.

Veterinary supervision.

Research-facility requirements.

Environmental protection.

Wildlife conservation.

Import and export controls.

A critical legal point is that the express prohibition in Article 4 of Law No. 47-14 concerns human reproductive cloning, not animal reproductive cloning.

Therefore, a general nationwide ban on animal cloning should not be inferred from that provision.

B. Restrictions on Embryo Creation and Manipulation

Animal cloning commonly requires embryo reconstruction and manipulation.

Research institutions must consider:

The lawful acquisition of biological material.

The health status of donor and recipient animals.

Veterinary supervision of embryo transfer.

The welfare of surrogate animals.

Monitoring of pregnancy complications.

The management of failed pregnancies and malformed offspring.

Morocco's human-embryo research prohibition under Law No. 47-14 cannot simply be extended to animal embryos.

The precise legal requirements for animal embryos must instead be assessed under applicable veterinary, animal-health and research rules.

C. Animal Welfare Restrictions

One of the most important issues is the welfare of animals used in cloning experiments.

Animal cloning can result in:

Failed embryo development.

Pregnancy complications.

Miscarriages.

Neonatal mortality.

Developmental abnormalities.

Pain and suffering during veterinary procedures.

Internationally recognised animal-research principles include the Three Rs:

World Animal Protection's Morocco assessment reports the absence of dedicated guidelines for animals used in scientific research and recommends introducing Three Rs protections and animal-research ethics committees.

This is an important regulatory gap, although the assessment is an independent policy evaluation rather than a Moroccan court judgment or statute.

Source: World Animal Protection – Morocco Assessment.

D. Restrictions on Genetically Modified or Cloned Animals

A cloning project may also involve genetic engineering, gene editing or other genetic interventions.

For example, a research project might clone a drought-resistant goat and subsequently modify its genetic characteristics.

This creates two separate legal questions:

Is the cloning procedure permissible under applicable animal-health and research requirements?

Does the genetic modification trigger additional biosafety, environmental or import restrictions?

Morocco's historical biosafety reporting indicates that research involving living modified organisms has faced significant regulatory limitations. However, the historical reporting should not be treated as proof that every present-day animal biotechnology experiment is prohibited.

Morocco+1

4. Intellectual Property Rights and Animal Cloning

Animal cloning also raises questions concerning patents, ownership of biological material and commercial exploitation.

Morocco's Law No. 17-97 on the Protection of Industrial Property, as amended, establishes the framework for patent protection.

Relevant considerations include:

Novelty of the invention.

Inventive step.

Industrial applicability.

Public order and morality.

Exclusions concerning animal breeds and biological breeding processes.

The Moroccan Industrial and Commercial Property Office (OMPIC) identifies animal breeds and essentially biological processes for obtaining plants or selecting animal breeds among the exclusions from patentability.

However, the law also recognises certain exceptions for technical inventions involving biological material and animals, subject to statutory conditions.

This distinction is important because a researcher may seek protection for a technical cloning apparatus, laboratory procedure or isolated biological material without necessarily obtaining an exclusive patent over an entire animal breed.

Sources: OMPIC – Patentability in Morocco and Law No. 17-97.

5. Regulatory Authorities Responsible for Animal Cloning Research

Several Moroccan institutions may have responsibilities depending on the nature of the research.

The National Office for Food Safety is particularly important because it exercises state responsibilities relating to animal and plant health and consumer protection.

ONSSA+1

6. Relevant Case Laws and Judicial Decisions

An important research limitation must be recognised: I could not identify a reported Moroccan court judgment directly deciding the legality of animal cloning research, SCNT experiments or the cloning of livestock.

Accordingly, the following authorities should be distinguished between Moroccan legislation and comparative judicial decisions. Comparative cases are useful for legal reasoning but are not binding Moroccan precedents.

Case 1. Brüstle v Greenpeace e.V. (2011)

Court of Justice of the European Union · Case C-34/10 · 18 October 2011

Legal issue: The case concerned the patentability of inventions involving human embryonic stem cells under European biotechnology patent law.

Decision: The Court interpreted the exclusion concerning the use of human embryos for industrial or commercial purposes.

Relevance to Morocco:

The decision illustrates how courts may consider human dignity and public policy when determining the limits of biotechnology patents.

However, this case concerned human embryos, not animal cloning.

It can provide comparative guidance when examining the ethical limits of biotechnology under Moroccan industrial property law, particularly Article 24 of Law No. 17-97.

Case 2. Harvard College v. Canada (Commissioner of Patents) (2002)

Supreme Court of Canada · 2002 SCC 76

Legal issue: Whether a genetically modified higher life form, the Harvard Oncomouse, could be patented under Canadian patent law.

Decision: The Supreme Court of Canada held that the genetically modified mouse was not patentable as a higher life form under the relevant Canadian legislation.

Relevance to Morocco:

This decision demonstrates the distinction between patenting a technical invention and claiming intellectual property rights over an entire living animal.

For Moroccan researchers, it provides comparative insight into the relationship between biotechnology innovation, animal breeds and patent exclusions.

It does not establish Moroccan law or determine whether a particular cloning technique is patentable in Morocco.

Case 3. Diamond v. Chakrabarty (1980)

United States Supreme Court · 447 U.S. 303 (1980)

Legal issue: Whether a genetically engineered microorganism could qualify as patentable subject matter.

Decision: The US Supreme Court accepted the patentability of the engineered microorganism under the applicable US patent legislation.

Relevance to Morocco:

The decision illustrates the importance of distinguishing naturally occurring biological material from technically produced biological inventions.

For animal cloning research, this distinction may help analyse patent applications involving:

Cloning technology.

Cell-culture systems.

Embryo manipulation techniques.

Laboratory equipment.

Technical biological processes.

The decision does not mean that cloned animals themselves are automatically patentable in Morocco.

Case 4. Monsanto Canada Inc. v. Schmeiser (2004)

Supreme Court of Canada · 2004 SCC 34

Legal issue: Patent infringement involving genetically modified canola plants.

Decision: The Court examined the use of patented genetic technology and the scope of patent rights.

Relevance to Morocco:

The case illustrates the importance of defining intellectual property rights over biological inventions and distinguishing ownership of biological material from patent rights over a technological invention.

This is relevant to possible disputes involving cloned livestock, patented cloning methods and commercial breeding arrangements.

Judicial significance: These four cases provide comparative biotechnology jurisprudence, not direct Moroccan authority on animal cloning.

7. Liability for Animal Cloning Research

Animal cloning may create civil, administrative and potentially criminal liability where applicable legal requirements are violated.

A. Civil liability

A research institution may face civil claims where negligent research causes foreseeable injury or damage.

Examples include:

Injury to surrogate animals.

Veterinary negligence.

Damage caused by improperly managed biological material.

Financial loss resulting from defective cloned livestock.

Breach of contractual obligations.

B. Administrative liability

Authorities may take regulatory action where an institution violates applicable licensing, animal-health, environmental or sanitary requirements.

Possible measures, depending on the applicable law, include suspension of activities, refusal of authorization, withdrawal of approvals and administrative penalties.

C. Criminal liability

Criminal liability may arise where conduct independently violates applicable criminal legislation, including offences relating to animal cruelty, illegal wildlife trade, fraud or public-health risks.

It would be incorrect, however, to assume that Morocco has a specific criminal offence of animal cloning merely because human reproductive cloning is prohibited.

8. Cross-Border Animal Cloning Research

International collaboration creates additional regulatory complications.

For example, a Moroccan research institution might import cloned cattle embryos from another country or collaborate with an overseas biotechnology company.

The following issues become important:

Import permits for animals and biological materials.

Veterinary health certification.

Quarantine and disease-control requirements.

Compliance with wildlife-trade restrictions where protected species are involved.

Intellectual property ownership.

International transfer of genetic material.

Environmental and biosafety assessments.

Law No. 28-07 and ONSSA's import and export control framework are particularly relevant to sanitary requirements.

ONSSA+1

For protected wildlife, Law No. 29-05 and applicable CITES requirements may also become relevant.

Maroc

9. Major Legal and Regulatory Challenges

Morocco faces several potential challenges in regulating animal cloning research.

10. Recommendations for Strengthening Moroccan Law

Morocco could strengthen its regulatory approach through the following measures.

1. Dedicated animal cloning legislation

A specific law or detailed implementing regulations should establish the legal conditions for animal cloning research, including the distinction between research cloning and reproductive cloning.

2. Mandatory research authorization

Institutions conducting animal cloning should be subject to appropriate registration, scientific review and regulatory authorization.

3. Animal ethics committees

Independent animal-research ethics committees should review research proposals before experimentation.

4. Three Rs principles

Replacement, Reduction and Refinement should be incorporated into binding animal-research standards.

5. Veterinary supervision

Qualified veterinary professionals should monitor donor animals, surrogate mothers, embryos and cloned offspring.

6. Genetic diversity protection

Cloning programmes should be evaluated for their potential effects on livestock genetic diversity and indigenous breeds.

7. Transparent research records

Researchers should maintain records concerning embryo development, pregnancy outcomes, animal mortality, veterinary interventions and abnormalities.

8. International cooperation

Morocco should strengthen cooperation with international veterinary and biosafety organisations to develop scientifically sound standards.

11. Conclusion

The regulation of animal cloning research in Morocco involves the interaction of agricultural law, animal-health legislation, environmental protection, food safety, wildlife conservation and intellectual property law.

Law No. 29-05 provides protection for wild animal species, Law No. 28-07 establishes food-safety requirements, and Law No. 17-97 governs the patentability of technological inventions. Law No. 47-14 expressly prohibits human reproductive cloning, but that prohibition must not be confused with a specific ban on animal cloning.

The principal legal difficulty is the absence of a clearly established, comprehensive animal-cloning-specific regulatory regime in the materials reviewed. Animal welfare oversight is also an important area requiring further development.

A comprehensive framework should balance scientific innovation, livestock improvement, biodiversity conservation, animal welfare and public safety.

Ultimately, animal cloning research in Morocco should be assessed according to the precise procedure, the species involved, the intended purpose and the applicable administrative and legal requirements.

12. Important Legal Sources and Further Reading

Law No. 29-05 – Protection of Wild Flora and Fauna.

Law No. 28-07 – Food Safety Framework.

Law No. 47-14 – Medically Assisted Reproduction.

Law No. 17-97 – Industrial Property.

Moroccan Environmental Legislation.

Morocco – Biosafety Clearing-House National Report.

World Animal Protection – Morocco Animal Welfare Assessment.

Academic research note: The comparative judgments above should not be cited as Moroccan precedents. For a Morocco-specific legal dissertation, it is important to distinguish enacted legislation, administrative policy, comparative case law and the absence of identified domestic judicial decisions directly concerning animal cloning.